Gilead Sciences (GILD) Change in Acquisitions & Divestments (2016 - 2025)
Gilead Sciences' Change in Acquisitions & Divestments history spans 17 years, with the latest figure at $822.0 million for Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments fell 57.59% year-over-year to $822.0 million; the TTM value through Dec 2025 reached $854.0 million, down 62.3%, while the annual FY2025 figure was $854.0 million, 62.3% down from the prior year.
- Change in Acquisitions & Divestments reached $822.0 million in Q4 2025 per GILD's latest filing, up from $17.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.3 billion in Q1 2024 to a low of -$1.9 billion in Q2 2024.
- Average Change in Acquisitions & Divestments over 5 years is $265.1 million, with a median of $211.0 million recorded in 2023.
- The largest YoY upside for Change in Acquisitions & Divestments was 1877.55% in 2024 against a maximum downside of 590.63% in 2024.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at -$1.1 billion in 2021, then soared by 103.9% to $42.0 million in 2022, then surged by 133.33% to $98.0 million in 2023, then soared by 1877.55% to $1.9 billion in 2024, then tumbled by 57.59% to $822.0 million in 2025.
- Per Business Quant, the three most recent readings for GILD's Change in Acquisitions & Divestments are $822.0 million (Q4 2025), $17.0 million (Q3 2025), and $15.0 million (Q2 2025).